Skip to main content
. 2011 Feb 16;36(6):1248–1259. doi: 10.1038/npp.2011.10

Figure 4.

Figure 4

Neither continuous (CONT-HAL) nor chronic and intermittent (INT-HAL) haloperidol (HAL) treatment altered conditioned stimulus-directed (a) or goal-directed (b) conditioned approach responses. n's=6–7 per condition. CONT-HAL, group receiving 0.5 mg/kg/day haloperidol through minipump; INT-HAL, group receiving 0.05 mg/kg/day haloperidol through daily subcutaneous injection. *p<0.05 compared with CONT-HAL and INT-HAL. AMPH, amphetamine.